|

recombinant zoster vaccine Clinical Trials

1 actively recruiting trial

Also known as: Shingrix®

Pipeline

Phase 4: 1

Top Sponsors

  • Prof Patrice Lalive1

Indications

  • Zoster1
  • Shingles1
  • Multiple Sclerosis1

Other1 trial

Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.